MARINUS PHARMACEUTICALS, INC. Contract with Customer, Asset, after Allowance for Credit Loss, Current
MARINUS PHARMACEUTICALS, INC. had Contract with Customer, Asset, after Allowance for Credit Loss, Current of $4.20 million as of 2021-06-30, per its 10-Q filed 2021-08-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:ContractWithCustomerAssetNetCurrent · last filed 2021-08-10
- 2021-06-30: Contract with Customer, Asset, after Allowance for Credit Loss, Current $4.20M.
- 2021-03-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $2.65M.
- 2020-12-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $1.65M.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss, Current |
|---|---|
| 2021-06-30 | $4.20M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $2.65M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.65M 10-Q · filed 2021-08-10 |